In this episode of Dry Eye Fireside Chat, Damon Dierker, OD, FAAO, and Julie McLaughlin, OD, ABO Diplomate, discuss when to consider using biologic treatments—such as amniotic membranes, cenergermin-bkbj, autologous serum tears, or platelet-rich plasma (PRP)—for patients with ocular surface disease, compared with more traditional therapies. Dry Eye Fireside Chat is independently editorial content supported by

advertising from Sun Ophthalmics. The information provided in this

article does not and is not intended to constitute medical advice;

instead, all information, content, materials available herein are for

general information purposes only.